Back

Teneligliptin attenuated AngII-induced cardiac hypertrophy by inhibiting Nox4-HDAC4 axis

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Cardiac remodelling Cardiac Hypertrophy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Kosuke Okabe

Fukuoka Red Cross Hospital, Fukuoka (Japan)

9 More presentations in this session

Presentation thumbnail
Specific MMP-9 and MMP-2 inhibition by novel MMP antibody attenuates LV remodeling secondary to volume overload
Mrs L. Cohen (Tel Aviv, IL)
Abstract
Presentation thumbnail
SLMAP expression is altered during cardiac remodeling and it regulates cardiomyocyte response to adrenergic stimuli
Associate Professor M. Nader (Riyadh, SA)
Abstract
Presentation thumbnail
Anti-inflammatory factor Del-1 protects from angiotensin II-induced hypertension and cardiovascular remodelling
Doctor I. Kopaliani (Dresden, DE)
Abstract
Presentation thumbnail
Cardiac nuclear high-mobility group box 1 attenuates angiotensin II induced pathological cardiac hypertrophy by inhibiting DNA damage response pathway
Doctor T. Takahashi (Yamagata, JP)
Abstract
Presentation thumbnail
Loss of akap1 exacerbates pressure overload-induced cardiac hypertrophy and failure
Mr N. Boccella (Napoly, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Cardiac remodelling

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Webinar
Elevating cardiac expertise: practical approach to left ventricular hypertrophy phenotypes assessment
thumbnail
Congress Presentation
Multimodality imaging in hypertrophied hearts
thumbnail
Congress Presentation
Contemporary treatment of hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources